We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FULC icon
801
Fulcrum Therapeutics
FULC
$248M
– –
-23,868
Closed -$220K
FULT icon
802
Fulton Financial
FULT
$4.73B
– –
-10,191
Closed -$190K
GBDC icon
803
Golub Capital BDC
GBDC
$3.38B
– –
-13,201
Closed -$181K
GBX icon
804
The Greenbrier Companies
GBX
$1.6B
– –
-7,321
Closed -$338K
TDAY
805
USA Today Co
TDAY
$1.27B
– –
-12,436
Closed -$51.4K
GCO icon
806
Genesco
GCO
$432M
– –
-11,713
Closed -$340K
GDYN icon
807
Grid Dynamics Holdings
GDYN
$513M
– –
-31,692
Closed -$244K
GH icon
808
Guardant Health
GH
$19B
– –
-4,366
Closed -$273K
GLDD
809
DELISTED
Great Lakes Dredge & Dock
GLDD
– –
-11,525
Closed -$138K
GNW icon
810
Genworth Financial
GNW
$3.85B
– –
-13,050
Closed -$116K
GPRK icon
811
GeoPark
GPRK
$601M
– –
-18,392
Closed -$117K
GRBK icon
812
Green Brick Partners
GRBK
$3.18B
– –
-5,320
Closed -$393K
GRFS
813
Grifois
GRFS
$5.44B
– –
-34,831
Closed -$347K
GRPN icon
814
Groupon
GRPN
$1.07B
– –
-11,696
Closed -$273K
GTES icon
815
Gates Industrial Corporation Ltd.
GTES
$6.69B
– –
-10,764
Closed -$267K
GTX icon
816
Garrett Motion
GTX
$5.6B
– –
-15,842
Closed -$216K
GVA icon
817
Granite Construction
GVA
$5.31B
– –
-2,854
Closed -$313K
HBM icon
818
Hudbay
HBM
$9.67B
– –
-15,069
Closed -$228K
HCSG icon
819
Healthcare Services Group
HCSG
$1.63B
– –
-10,480
Closed -$176K
HDSN
820
Hudson Technologies
HDSN
$259M
– –
-31,799
Closed -$316K
HEI icon
821
HEICO Corp
HEI
$50.8B
– –
-664
Closed -$214K
HEI.A icon
822
HEICO Corp Class A
HEI.A
$36.8B
– –
-1,674
Closed -$425K
HGV icon
823
Hilton Grand Vacations
HGV
$4.14B
– –
-6,020
Closed -$252K
HL icon
824
Hecla Mining
HL
$9.76B
– –
-17,789
Closed -$215K
HLIO icon
825
Helios Technologies
HLIO
$2.56B
– –
-6,370
Closed -$332K
31 32
33
34 35

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.